Objective:To study the clinical efficacy of autologous peripheral blood hematopoietic stem cell transplantation(APBSCT) in the treatment of non-Hodgkin’s lymphoma(NHL). Methods:A total of 56 patients who underwent APBSCT from February 2009 to October 2013 in the hospital were enrolled in the study. There were 37 males and 19 females with a median age of 44 years(16-69 years);46 cases were in remission,7 cases in partial remission and 3 cases in relapsed or refractory. Results:Among 56 patients treated by APBSCT,55 patients obtained hematopoi-etic reconstitution. The median time for neutrophils recovery(>0.5×109/L) was 9.5(7-18) d and platelet recovery(>20×109/L) was 11.5(6-24) d. Twenty-four patients experienced fever during granulocyte lack phase,5 patients experienced mild-to-moderate diarrhea,one patient had mild liver function damage and one patient had herpes zoster. All patients were followed up till the 1st April,2014,and the median follow-up time was 20.25(3-60.5) months. Forty-five cases survived(5 cases alive with disease);10 cases relapsed;11 cases died(5 cases died of recurrence). The recurrence rate was 17.9%. Overall survival and disease-free survival were 80.4% and 71.4% respectively. Conclusion:With the advantages of quicker hematopoietic reconstruction and fewer non-Hodgkin’s lymphoma,APBSCT is effective in the treatment of NHL.